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Summary.-A population of human AML cells which have a characteristic karyo-
typic marker was cryopreserved and then grown in short-term liquid culture for 2
weeks, during which time the cells increased about 7-fold in number and progres-
sively acquired characteristics of macrophages. 107 cells obtained after 1 day in cul-
ture, when they were almost devoid ofFc receptors (Fc-), on inoculation into immune-
deprived mice gave rise to tumours in more than90%o of the animals. However, after
13 days ofculture, when almost all the cells had Fc receptors (Fc+), a similar inoculum
did not grow as tumours. After 7 days in culture the cells were heterogeneous, and
divided about equally into Fc+ and Fc- cells, both of which were replicating. The Fc-
population was capable of producing tumours, whereas the Fc+ was not. Of23 assess-
able xenograft tumours produced by the AML cells, 14 regressed completely, 4 grew
progressively and 5 grew progressively after initial regression. Progressive tumours
could be further transplanted. The regressions may arise as a result of maturation
in vivo similar to that seen in vitro.
A POPULATION of cryopreserved human
AML cells was available in our laboratory
which grew proliferatively for 2 weeks in
liquid culture. The detailed histochemical
enzymatic and surface characteristics of
these cells and their progressive changes in
culture are the subject of a comprehensive
report (Palu et al., 1979). We showed that
dividing cells in culture, regardless of
phenotype, carried a characteristic abnor-
mality of Chromosome Number 11. The
purpose ofthis investigation was to exam-
ine whether it was possible to produce
transplantable xenografts from this cell
population and to compare in vivo tumori-
genicity with the gradual maturation
towards macrophages which occurs in
vitro. In earlier investigations, Franks et al.
(1977) had reported that AML cells taken
directly from patients gave rise to small
tumours in immune-deprived mice, but
that these regressed. A further objective of
this study was, therefore, to determine
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whether progressively growing xenografts
could be obtained from AML cells grown
for short periods in vitro and not having
the properties of established tissue-culture
cell lines.
MATERIALS AND METHODS
AML cells-.One population of AML cells
was studied. They were removed using a
Blood Cell Separator (Powles et al., 1974)
from an untreated 17-year-old female with
AML, whose WBC count was 96-6 x 109/1.
They were then stored in liquid N2 and
karyotyped as described in Chapuis et al.
(1977) and Palu' etal. (1979).
Culture conditions were as described in
those papers.
Technique for proliferative cultures of AML
cells-.Cultures were established in 35mm
Petri dishes as described by Palu' et al (1979).
The cells growing in suspension were counted
with a standard haemacytometer. Cells ad-
herent to the plate were enumerated in situ
with a calibrated objective, or alternativelyG. PALU, P. SELBY, R. POWLES AND P. ALEXANDER
after the nuclei had been detached from the
cytoplasm with 0 1M citric acid.
Cells synthesizing DNA.-Their number
was estimated after incubation with [3H]-
TdR at 1 ,uCi/ml (37 KBq/ml) (sp. act. 20/30
Ci/mM (740-1110 GBq/mM)) for 3 h. Auto-
radiographs were performed on fixed cells
using a conventional dipping technique and
Ilford K 5 emulsion. Films were exposed in
the dark for 7-10 days, developed and stained
with Giemsa. At least 500 cells were counted
todetermine the labellingindex.
Fc receptors (EA rosettes).-Non-adherent
cells forming rosettes with sensitized sheep
erythrocytes were determined as previously
described by Palui et al. (1979).
Separation ofFc+ from Fc- cells.-Some of
the cells growing in suspension adhered to
the plastic culture dish in absence of serum,
and those cells which remained non-adherent
under these conditions were wholly Fc-. If,
to the cells which had adhered to plastic in
the absence of serum, serum is added for
-12 h at 37°C, the majority of the cells
detached and more than 90% of these were
Fc+. This simple method of separation was
preferred to other fractionation procedures to
obtain large numbers of cultured AML cells
which were Fc+ or Fc- respectively, to study
their DNA synthetic capacity and growth in
animals.
Xenografts.-Male CBA mice were used,
whichhadbeenrenderedimmuno-deprived by
neonatal thymectomy, followed after 2-4
weeks by a priming dose of Ara-C 200 mg/kg
and 900R total body irradiation as described
(Steel et al., 1978; Millar et al., 1978). The
animals were prepared by Mr E. M. Merry-
weather of the Division of Biophysics animal
department. AML cells were injected s.c.
in the dorsal anterior region of the animals,
after having been cultured for 1, 7, 13 days
and on occasion separated into Fc+ and Fc-
populations by adherence. Tumour growth
was measured with a caliper, recording 2
diameters at right angles of the s.c. nodules.
Cellular composition ofxenograft tumours.
After removal ofgrowths of between 0-3 and
0-7 cm diameter, they were cut into small
fragments and a cell suspension made by
dissociation in0-1% trypsin, 0.1% collagenase
and 0.01% DNAse. The cells so obtained
were tested for Fc receptors immediately
after enzymatic dispersion and after 24h
culture. The percentage ofmouse cells present
within these tumours was assayed using a
CBA anti-human serum in complement-
dependent lysis. The antiserum was obtained
after multiple immunization of normal male
CBA with the same AML population used
for tumour induction in the immune-deprived
CBA. Lyophilized rabbit serum served as the
source of complement, after adsorption with
AML cells. Cytochemical studies were as
described byPalui etal. (1979).
RESULTS
Invitro maturation andproliferation
The figure shows that the AML cells
recovered from cryopreservation prolifer-
ateinliquid culture andincrease innumber
about 7-fold over a period of 2 weeks.
The culture consists of 2 types of cells,
those that remain in suspension and those
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FIG. Maturation of AML cells in a 3ml
liquid culture. A total number of cells.
0 FC+ non-adherent cells (enumerated by
a haemacytometer count. A Fc- non-
adherent cells. 0 cells adhering to the
Petri dish and enumerated by counting
nuclei detached by citric acid treatment.
The initial inoculum was 106 viable cells
recovered from cryopreservation.
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TABLE I.-DNA synthesis of AML cells
in short-term culture
Days in
culture
1
7
7
7
13
13
Cell sample Labelling
index (%)
Total 30
Fc+ and Fe- (non-adherent) 20
Fc+ 14
Fc- 31
Total non-adherent 4
Adherent < 0-5
which adhere firmly to the culture vessel.
Significant numbers of adherent cells only
become apparent after 7 days of culture,
and constitute 20% ofthe total cellpopula-
tion by Day 13. The non-adherent popula-
tion undergoes progressive change during
culture as demonstrated by the appear-
ance of Fc receptors. Initially, Fc+ cells
constitute a small proportion, but even-
tually 90% of all the non-adherent cells
acquire Fc receptors (all the adherent cells
are always Fc+). Table I shows that both
Fc- and Fc+ non-adherent cells synthesize
DNA, and inspection of the figure shows
that Fc+ non-adherent cells contribute to
the increase in cell numbers. The adherent
cells have a very low labelling index; in
experiments (not reported) in which ad-
herent cells alone were cultured, there was
no DNA synthesis or increase in cell num-
ber. We conclude that the pattern of
maturation is first the acquisition of Fc
receptors, and these cells retain the
capacity to divide in vitro and retain the
characteristic karyotypic abnormality.
Subsequently they acquire macrophage-
like properties as described first by
Balkwill and Oliver (1976).
Xenografts
Table II shows that the AML cells after
24h culture, when only 10% carried Fc
receptors, (90% Fc- cells) consistently
produced nodules when inoculated into
immuno-deprived mice. When the number
of inoculating cells was less than 107, the
cells grew as xenografts in 64% of the
animals (7/11). However, if 107 or more
cells were inoculated tumours were almost
invariably obtained (92%; =23/25).
Whilst most of the tumours regressed
spontaneously, we observed (unlike
Franks, 1977) that after inoculation of
107 cells 40% of the assessable tumour
nodules grew progressively, although half
of these showed an initial regression (see
Table II). Progressively growing tumours
could be further transplanted. Morpho-
logically these tumours were human AML
cells, with many mitotic figures showing
the characteristic chromosome marker of
this population. The nodules were dis-
persed enzymatically, and more than 95%
ofthe resulting cells were lysed by a mouse
anti-human serum in the presence of
complement.
TABLE II.-Growth ofAML cells after differentperiods ofculture in immune-deprived mice
Length of
culture
(days)
1
Cell sample
7 Total (- 50% Fc+)
Fe-
Fc+
13 , 90% Fc+
1
13
* A nodule exceeding 5 mm in diameter appearing within 3 weeks of inoculation.
t The total disappearance of a nodule which occurred within 2-5 weeks of inoculation.
$ Continuous growth for more than 60 days, leading to a large lesion which required that the mouse be
killed.
Inoculum
(cell no.)
1 X 106
3 x 106
7 x 106
1 X 107
1 X 107
1 X 107
1 X 107
1 X 107
1 X 107
5 X 106
No of
mice
inoculated
3
4
4
25
7
7
4
10
3
Takes*
2
2
3
23
3
6
0
0
3
Regressorst
1/2
2/2
3/3
14/23
3/3
6/6
0
0
0
Progressorst
1
0
0
9
0
0
0
0
3
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TABLE III. Properties of cells derived frorn AML xenografts which developed from an
inoculum of 107 AML cells cultured for 1 day
Time of
excision after 0° non-
implantationi No. of °, % specific
(weeks) animals MHouse Fc+ esterase±
,3* 3 1 70 40
17t 2 1 9 15
Inoculated cells 9 20
* XThein nodules wNere iegressing.
t Progressively growing tumours.
Cells culture(d for 7 days grew as xeno-
grafts in 3/7 mice (Table II). The inocu-
lated cells consistedofabout equalnumbers
of Fc+ and Fc- cells, both of which, as
shown in Table I, synthesized DNA. After
separation by in vitro adherence into 2
populations which were respectively
> 900o Fc+ and < 10% Fc+, only the Fc-
cells grew as xenografts. In each of the 6
instances, the tumours derived from the
cells that had been cultured for 7 days
regressed even though the inoculum con-
sisted of 107 cells.
After 13 days of culture the non-
adherent cells which were viable (i.e.
excluded trypan blue) and looked morpho-
logically normal failed to grow as xeno-
grafts in 10 animals tested. More than 9000
of these cells were Fc+ and 7000 were
positive for nonspecific esterase activity.
However, these Fc+ cells did not appear to
inhibit the growth in vivo of the Fe- cells,
since in one experiment involving 3
animals, 107 Fe- (Day 1 culture) cells
when inoculated admixed with 5 x 106
Fc+ (Day 13) cells grew as xenografts (see
Table II).
Table III provides some evidence that
theregression ofxenografts is accompanied
by maturation. Cells derived from tu-
mours which had passed their maximum
size of - 7 mm in diameter, and at
excision were in the range of 4 cm in
diameter, had agreatly increased incidence
of Fc+ and nonspecific-esterase-positive
cells than the original inoculum. Matura-
tion was much less evident in the 2 pro-
gressively growing tumours studied.
DISCUSSION
Franks et al. (1977) found that AML cells
taken directly from the blood of patients,
grew in thymectomized, irradiated mice
reconstituted with marrow as s.c. tumours
for 2-3 weeks, and then regressed. We find
that a population of cryopreserved AML
cells will take as xenografts in 9000 of
mice that had been immune-deprived by
a procedure that did not involve marrow
grafting, and a chromosome marker shows
that the dividing cells in the tumour were
of leukaemic origin. Using a suitable anti-
human mouse serum it was found that
there are very few mouse cells in these
tumours. 40% of the nodules grow pro-
gressively and can be transplanted into
other immune-deprived animals, in which
they grow progressively. Maturation of
the AML cells in culture, as revealed by
acquisition of Fc receptors, is associated
with loss of tumorigenicity. Thus Fc+ cells
obtained from proliferative cultures after
9-14 days in liquid media fail to grow as
xenografts in spite of the fact that the
cells divide (Table I).
A remarkable aspect of the growth as
xenografts of the AML cells, either when
taken directly from the patient or from
short-term culture, is the high incidence
of spontaneous regression of the nodules
after 2-3 weeks. The regression of these
Fe- AML cells is unlikely to be caused by
an immune rejection, since ifthis were the
case we would anticipate an inverse rela-
tionship between the size of the cell
inoculum and the incidence of regression,
but this is not found (see Table II). But,
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more importantly, mice that had been
inoculated and developed a tumour which
regressed, when rechallenged with 107
Fe- cells developed tumours which then
again regressed in 2 ofthe 3 mice in which
this experiment was performed. This
pattern is not compatible with an inter-
pretation of the regression as an immune
rejection caused by the partial recovery
of immune function ofthe mice with time.
Some evidence that the regression ofthe
xenografts is associated with maturation
similar to that occurring in vitro is pro-
vided by experiments measuring Fc recep-
tors of the cells in the xenografts before
rejection. The percentage of Fc+ cells
determined immediately and after 24h of
culture showed that up to 70%0 ofthe cells
were Fc+, although less than 10% were
Fc+ when inoculated. The cells derived
from the xenograft tumours also appeared
more mature than the inoculated cells,
as they had an increased nonspecific
esterase staining, a change which is also
seen after 7 days of in vitro culture. The
experiments reported show that this
population of AML cells, studied and
identified karyotypically, undergoes in
vitro progressive changes towards a macro-
phage phenotype which is unable to divide.
At an intermediate stage in the in vitro
cultures (7 days) some cells have acquired
Fc receptors, and these do not then grow
as tumours in immune-deprived mice, in
spite of retaining the capacity to divide
in vitro. The spontaneous regression of the
AML xenografts may also be the result of
this differentiation. These findings raise
the possibility that interference with
maturation may be a component of AML
in man.
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